No black box warning on record for Ilevro

As of the latest FDA labeling reviewed, Ilevro (NEPAFENAC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ilevro medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Increased bleeding time due to interference with thrombocyte aggregation ( 5.1 ) Delayed healing ( 5.2 ) Corneal effects including keratitis ( 5.3 ) 5.1 Increased Bleeding Time With some NSAIDs including ILEVRO ® 0.3%, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied non

No black box warning on record for Ilevro

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Increased bleeding time due to interference with thrombocyte aggregation ( 5.1 ) Delayed healing ( 5.2 ) Corneal effects including keratitis ( 5.3 ) 5.1 Increased Bleeding Time With some NSAIDs including ILEVRO ® 0.3%, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied non

Ilevro Black Box Warning

No black box warning on record for Ilevro

Other warnings & precautions

Ilevro Black Box Warning

No black box warning on record for Ilevro

Other warnings & precautions